Static and dynamic 68Ga-FAPI PET/CT for the detection of malignant transformation of intraductal papillary mucinous neoplasia of the pancreas
M Lang, AM Spektor, T Hielscher… - Journal of Nuclear …, 2023 - Soc Nuclear Med
Pancreatic ductal adenocarcinoma (PDAC) may arise from intraductal papillary mucinous
neoplasms (IPMN) with malignant transformation, but a significant portion of IPMN remains …
neoplasms (IPMN) with malignant transformation, but a significant portion of IPMN remains …
Additional value of FDG PET/CT to contrast-enhanced CT in the differentiation between benign and malignant intraductal papillary mucinous neoplasms of the …
K Takanami, T Hiraide, M Tsuda, Y Nakamura… - Annals of nuclear …, 2011 - Springer
Objectives This study aimed at determining the additional value of FDG PET/CT to contrast-
enhanced CT in the differentiation between benign and malignant intraductal papillary …
enhanced CT in the differentiation between benign and malignant intraductal papillary …
The utility of F-18 FDG PET/CT in the evaluation of pancreatic intraductal papillary mucinous neoplasm
Purpose: To assess the utility of F-18 fluorodeoxyglucose positron emission
tomography/computed tomography (FDG PET/CT) in evaluating pancreatic intraductal …
tomography/computed tomography (FDG PET/CT) in evaluating pancreatic intraductal …
Usefulness of positron emission tomography (PET)/contrast-enhanced computed tomography (CE-CT) in discriminating between malignant and benign intraductal …
K Ohta, M Tanada, Y Sugawara, N Teramoto, H Iguchi - Pancreatology, 2017 - Elsevier
Abstract Background/Objectives We evaluated the usefulness of positron emission
tomography (PET)/contrast-enhanced computed tomography (CE-CT) in discriminating …
tomography (PET)/contrast-enhanced computed tomography (CE-CT) in discriminating …
Usefulness of 18-FDG PET/CT in detecting malignancy in intraductal papillary mucinous neoplasms of the pancreas
YI Yamashita, H Okabe, H Hayashi, K Imai… - Anticancer …, 2019 - ar.iiarjournals.org
Background/Aim: Identifying malignancy in intraductal papillary mucinous neoplasm (IPMN)
of the pancreas remains challenging. This study aimed to evaluate the usefulness of 18 …
of the pancreas remains challenging. This study aimed to evaluate the usefulness of 18 …
18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the …
C Sperti, S Bissoli, C Pasquali, L Frison, G Liessi… - Annals of …, 2007 - journals.lww.com
Objective: To assess the reliability of 18-fluorodeoxyglucose positron emission tomography
(18-FDG PET) in distinguishing benign from malignant intraductal papillary mucinous …
(18-FDG PET) in distinguishing benign from malignant intraductal papillary mucinous …
[HTML][HTML] Possible additional value of 18FDG-PET in managing pancreas intraductal papillary mucinous neoplasms: preliminary results
GL Baiocchi, N Portolani, F Bertagna, F Gheza… - Journal of Experimental …, 2008 - Springer
Although some clinical and radiological features may predict malignancy presence in
intraductal papillary mucinous pancreas neoplasms, preoperative diagnosis remains …
intraductal papillary mucinous pancreas neoplasms, preoperative diagnosis remains …
The value of 18F-FDG positron emission tomography to differentiate benign from malignant intraductal papillary mucinous neoplasms: A prospective multicenter study
N Regenet, A Sauvanet, F Muscari, B Meunier… - Journal of visceral …, 2020 - Elsevier
Objective To assess the value of 18 F-FDG PET/CT in differentiating between benign and
malignant intraductal papillary mucinous neoplasms (IPMN) of the pancreas. Summary …
malignant intraductal papillary mucinous neoplasms (IPMN) of the pancreas. Summary …
Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography in differential diagnosis of benign and malignant intraductal papillary-mucinous neoplasm of …
Y Tomimaru, Y Takeda, M Tatsumi… - Oncology …, 2010 - spandidos-publications.com
Intraductal papillary-mucinous neoplasm (IPMN) of the pancreas presents in various
histopathological stages from benign to malignant lesions. The differentiation between …
histopathological stages from benign to malignant lesions. The differentiation between …
[HTML][HTML] The role of positron emission tomography in clinical management of intraductal papillary mucinous neoplasms of the pancreas
S Serafini, C Sperti, AR Brazzale, D Cecchin… - Cancers, 2020 - mdpi.com
Intraductal papillary mucinous neoplasms (IPMNs) of the pancreas represent a
heterogeneous group of tumors, increasingly diagnosed in clinical practice. An early …
heterogeneous group of tumors, increasingly diagnosed in clinical practice. An early …